Score Your Stock

US stock · figures in US dollars · scored on full-year results

Waters Waters Corporation Common Stock

WAT · Healthcare · Diagnostics & Research
Bottom 9% of scored stocks
WeakBottom 9% of scored stocks
Weak SpotLimited Data

Waters scores 37/100 on fundamentals: in the bottom 9% of 503 scored S&P 500 stocks. Its strongest area is Financial Safety (83/100); its weakest is Price Fairness (0/100). It carries 2 warning flags: Weak Spot, Limited Data.

Best
Financial 83
Weakest
Price 0
  • Carries a Weak Spot flag
  • Carries a Limited Data flag

A financially strong, expensively priced stock, but price fairness needs attention.

What looks good
What to watch
Mkt capUS$ 45.4b#251 of 503 in the S&P 500EPSUS$ 3.95P/E272.8×✗ vs sector median 29.6×P/B3×✓ vs sector median 4×Div yieldNo dividends paidBottom 1% in the S&P 50052w range · 90% of range282.77482.28
as of 31 Oct 2026

Nearby peers

Ranks #53 of 60 in Healthcare by score

#1Universal Health Services79#51Humana39#52UnitedHealth Group37
#53Waters37
#54Viatris36#55Baxter International35

One-Minute Summary

Why Waters scores 37

A financially strong, expensively priced stock, but price fairness needs attention.

What looks good
What to watch

Business Strength

25
Why 25?
Pillar score: (0 + 2 + 0 + 0) = 2 of 8 points → 25 · 1 N/A skipped
Return on Equity (ROE)1%Weak4-Year Revenue Growth+16%/yrStrong4-Year Profit Growth-36%/yrWeakNet Profit Margin4%Weak

No data: Quarterly Momentum

Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -74.1%Equity ↑ +1,221%ROE % 1.1%
Net ProfitEquityROE %
642m638m643m167m1.2b1.8b2.6b15.2b202320242025TTM55.8%34.9%25.1%1.1%

Revenue & Net Profit, with Net Margin

Revenue ↑ +57.1%Net Profit ↓ -74.1%Net Margin % 3.6%
RevenueNet ProfitNet Margin %
3.0b3.0b3.2b4.6b642m638m643m167m202320242025TTM21.7%21.6%20.3%3.6%

Sales grew about 57.1% over 4 years: customers keep spending more with this company.

Profit fell about 74.1% from where it was 4 years ago: the boom has cooled off.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +158.3%Net Profit ↓ -233.1%Net Margin % -8.3%
RevenueNet ProfitNet Margin %
637m662m662m771m800m932m1.3b1.6b102m121m121m147m149m225m-72m-136mQ1'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'2616%18.3%18.3%19.1%18.6%24.2%-5.7%-8.3%
▼▼▼▲▲▲▼▼

Sales grew about 158.3% over the last 8 quarters: customers keep spending more with this company.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 83?
Pillar score: (2 + 2 + 1) = 5 of 6 points → 83
Debt-to-Equity0.4×StrongCurrent Ratio1.9×StrongInterest Coverage2.4×Okay
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +123.3%Equity ↑ +1,221%D/E 0.4×
Total DebtEquityD/E
2.4b1.7b1.5b5.5b1.2b1.8b2.6b15.2b202320242025TTM2.1×0.9×0.6×0.4×

Borrowings grew about 123.3% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +154.7%Current Liabilities ↑ +203.8%Current Ratio 1.9×
Current AssetsCurrent LiabilitiesCurrent Ratio
1.8b1.7b2.1b4.5b790m790m1.2b2.4b202320242025TTM2.2×2.1×1.7×1.9×
Why 63?
Pillar score: (0 + 1 + 2 + 2) = 5 of 8 points → 63
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive & growingStrongCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -8.8%Free CF ↓ -9.8%
Operating CFFree CF
603m762m653m550m442m620m540m399m202320242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↑ +36.4%Total Debt ↑ +123.3%
CashTotal Debt
395m325m588m539m2.4b1.7b1.5b5.5b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 0?
Pillar score: (0 + 0 + 0) = 0 of 6 points → 0
P/E Ratio272.8×WeakP/B Ratio3×WeakPEG Ration/m (growth not measurable)Weak
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 462.72US$ 374.64US$ 286.57Oct '25Feb '26Jun '26Oct '26

The share price is up about 32.4% over the past year.

Why 10?
Pillar score: (1 + 0 + 0 + 0 + 0) = 1 of 10 points → 10 · 1 N/A skipped
Earnings ConsistencyUnevenOkayDebt Trend (4yr)RisingWeakShare Count Trend (4yr)+18%/yrWeakInventory vs Sales (4yr)+22.4 pp/yr vs salesWeakAsset Turnover Trend (4yr)-70.6%Weak

No data: Quarterly Consistency

Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +57.1%Inventory ↑ +166.8%Inv. % of Rev. 29.6%
RevenueInventoryInv. % of Rev.
3.0b3.0b3.2b4.6b516m477m572m1.4b202320242025TTM17.5%16.1%18.1%29.6%
Ranks #53 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#51Humana39#52UnitedHealth Group37
#53Waters (you)37
#54Viatris36#55Baxter International35

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 4.6bUS$ 166.6mUS$ 549.6mUS$ 398.8mUS$ -150.7mUS$ 539.0mUS$ 5.5bUS$ 200.0mUS$ 15.2bUS$ 4.5bUS$ 2.4bUS$ 24.8bUS$ 9.6bUS$ 1.4b-1%4%0.4×1.9×2.4×----
2025US$ 3.2bUS$ 642.6mUS$ 652.6mUS$ 539.8mUS$ -112.7mUS$ 587.8mUS$ 1.5bUS$ 460.0mUS$ 2.6bUS$ 2.1bUS$ 1.2bUS$ 5.1bUS$ 2.5bUS$ 572.4mUS$ 0.0m25%20%0.6×1.7×11.9×0%35.4×8.9×-
2024US$ 3.0bUS$ 637.8mUS$ 762.1mUS$ 619.6mUS$ -142.5mUS$ 325.4mUS$ 1.7b-US$ 1.8bUS$ 1.7bUS$ 789.8mUS$ 4.6bUS$ 2.7bUS$ 477.3mUS$ 0.0m35%22%0.9×2.1×9.4×0%34.6×12.1×-
2023US$ 3.0bUS$ 642.2mUS$ 602.8mUS$ 442.2mUS$ -160.6mUS$ 395.1mUS$ 2.4bUS$ 50.0mUS$ 1.2bUS$ 1.8bUS$ 789.6mUS$ 4.6bUS$ 3.5bUS$ 516.2mUS$ 0.0m56%22%2.1×2.2×8.5×0%30.3×16.9×4.2